Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Doro Shin

Content Marketing Director

Califonia, USA

Doro Shin heads the content marketing strategy and development for Pharma Intelligence, which provides insight on key trends in the pharma industry.

Her key achievements include managing, and producing, thought leadership, showcasing the individual and synergistic strengths of Pharma Intelligence analysts and services while overseeing content marketing strategy.

She joined Citeline, part of Informa, in 2007 as a Trialtrove analyst, and was responsible for the editorial content of Trialtrove for infectious diseases and genitourinary conditions, specializing in HIV and HCV. After regularly contributing to Citeline’s Thought Leadership, Doro began managing the program in 2015.

Before Informa, she spent 3 years at the University of California, San Francisco’s Women’s Global Health Imperative and managed Phase III HIV prevention clinical trials based in Zimbabwe. She has an MPH specializing in infectious diseases from UC Berkeley, and a BA in English Literature from the University of Pennsylvania.

Set Alert for Articles By Doro Shin

Latest From Doro Shin

Pharma Intelligence Congratulates The CARE Awards Winners

The fourth annual CARE Awards returned to Boston, Massachusetts, 2 May to once again recognize and commend key achievements across the spectrum of drug development that took place in 2018.
Clinical Trials Innovation

R&D Successes Celebrated At 2018 CARE Awards

Informa Pharma Intelligence pays tribute to the people driving the advances in drug development and their commitments to advancing human health with the third annual CARE Awards.

BioPharmaceutical Research & Development

R&D Successes Celebrated At 2018 CARE Awards

Informa Pharma Intelligence pays tribute to the people driving the advances in drug development and their commitments to advancing human health with the third annual CARE Awards.

BioPharmaceutical Research & Development

A Status Check Of The Alzheimer’s Trial Landscape

Despite high-profile failures, including the recent disappointing results for Axovant Science’s Phase III MINDSET study, the trial landscape for Alzheimer’s disease remains busy.

Scrip 100 Clinical Trials

Global Guidelines

A sampling of global guidelines on the use of genomic biomarkers in drug development.

BioPharmaceutical

One Size No Longer Fits All: The Personalized Medicine Trial Landscape

Success rates are higher for clinical trials that incorporate selective pharmacogenomics and pharmacogenetics (PGX) biomarkers, according to data from Informa's Trialtrove. Given the challenges of designing and administering trials to secure regulatory approval in areas of unmet medical need, the data provide some basis for optimism in realizing the promise of targeted, personalized therapies that improve health outcomes for individual patients.

Personalized Medicine Clinical Trials
See All
UsernamePublicRestriction

Register